These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1076 related items for PubMed ID: 28017326

  • 1. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Keskar V, McArthur E, Wald R, Harel Z, Zimmerman D, Molnar AO, Garg AX, Lam NN, McCallum MK, Bota SE, Perl J, Sood MM.
    Kidney Int; 2017 Apr; 91(4):928-936. PubMed ID: 28017326
    [Abstract] [Full Text] [Related]

  • 2. Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
    Kumar S, de Lusignan S, McGovern A, Correa A, Hriskova M, Gatenby P, Jones S, Goldsmith D, Camm AJ.
    BMJ; 2018 Feb 14; 360():k342. PubMed ID: 29444881
    [Abstract] [Full Text] [Related]

  • 3. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.
    Shin JI, Secora A, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.
    Clin J Am Soc Nephrol; 2018 Aug 07; 13(8):1144-1152. PubMed ID: 30002224
    [Abstract] [Full Text] [Related]

  • 4. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
    Palamaner Subash Shantha G, Bhave PD, Girotra S, Hodgson-Zingman D, Mazur A, Giudici M, Chrischilles E, Vaughan Sarrazin MS.
    Circ Cardiovasc Qual Outcomes; 2017 Apr 07; 10(4):. PubMed ID: 28408716
    [Abstract] [Full Text] [Related]

  • 5. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX, Malo S, Svenson LW, Wilton SB, Hill MD.
    J Am Heart Assoc; 2017 Oct 28; 6(11):. PubMed ID: 29080863
    [Abstract] [Full Text] [Related]

  • 6. Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Ogata T, Matsuo R, Kiyuna F, Hata J, Ago T, Tsuboi Y, Kitazono T, Kamouchi M, FSR Investigators.
    J Am Heart Assoc; 2017 Aug 15; 6(8):. PubMed ID: 28862939
    [Abstract] [Full Text] [Related]

  • 7. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
    Szummer K, Gasparini A, Eliasson S, Ärnlöv J, Qureshi AR, Bárány P, Evans M, Friberg L, Carrero JJ.
    J Am Heart Assoc; 2017 Mar 01; 6(3):. PubMed ID: 28249846
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB, Larsen TB, Skjøth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY.
    Circulation; 2015 Aug 11; 132(6):517-25. PubMed ID: 26059010
    [Abstract] [Full Text] [Related]

  • 12. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation.
    Kai B, Bogorad Y, Nguyen LN, Yang SJ, Chen W, Spencer HT, Shen AY, Lee MS.
    Heart Rhythm; 2017 May 11; 14(5):645-651. PubMed ID: 28185918
    [Abstract] [Full Text] [Related]

  • 13. Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study.
    Wakasugi M, Kazama JJ, Tokumoto A, Suzuki K, Kageyama S, Ohya K, Miura Y, Kawachi M, Takata T, Nagai M, Ohya M, Kutsuwada K, Okajima H, Ei I, Takahashi S, Narita I.
    Clin Exp Nephrol; 2014 Aug 11; 18(4):662-9. PubMed ID: 24113782
    [Abstract] [Full Text] [Related]

  • 14. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.
    Thromb Haemost; 2009 May 11; 101(5):938-42. PubMed ID: 19404548
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M, Sheu TC, Mott K, Goulding MR, Houstoun M, MaCurdy TE, Worrall C, Kelman JA.
    Circulation; 2015 Jan 13; 131(2):157-64. PubMed ID: 25359164
    [Abstract] [Full Text] [Related]

  • 16. Ischemic stroke and non-valvular atrial fibrillation: When to introduce anticoagulant therapy?
    Boursier-Bossy V, Zuber M, Emmerich J.
    J Med Vasc; 2020 Apr 13; 45(2):72-80. PubMed ID: 32265018
    [Abstract] [Full Text] [Related]

  • 17. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG, Eikelboom JW, Brimble KS, McMurtry MS, Ingram AJ.
    Can J Cardiol; 2013 Jul 13; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Villines TC, Schnee J, Fraeman K, Siu K, Reynolds MW, Collins J, Schwartzman E.
    Thromb Haemost; 2015 Nov 25; 114(6):1290-8. PubMed ID: 26446456
    [Abstract] [Full Text] [Related]

  • 19. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 20. Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2 DS2 VASc 1 or 2): A treatment dilemma.
    Denas G, Zoppellaro G, Padayattil Jose S, Antonucci E, Marongiu F, Poli D, Testa S, Tripodi A, Palareti G, Pengo V.
    Cardiovasc Ther; 2018 Feb 01; 36(1):. PubMed ID: 29078033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.